Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 25728540)

Published in Helicobacter on March 01, 2015

Authors

Galit H Frydman1, Nick Davis1, Paul L Beck2, James G Fox1

Author Affiliations

1: Department of Biological Engineering, Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
2: The Gastrointestinal Research Group, Division of Gastroenterology, University of Calgary, Calgary, AB, Canada.

Articles cited by this

(truncated to the top 100)

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62

Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. Proc Natl Acad Sci U S A (2005) 10.22

International consensus report on the investigation and management of primary immune thrombocytopenia. Blood (2009) 7.72

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood (2008) 7.06

An African origin for the intimate association between humans and Helicobacter pylori. Nature (2007) 6.91

Clines, clusters, and the effect of study design on the inference of human population structure. PLoS Genet (2005) 6.73

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood (2011) 6.50

Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A (1999) 6.34

Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07

Geography predicts neutral genetic diversity of human populations. Curr Biol (2005) 4.74

Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29

Platelets and the immune continuum. Nat Rev Immunol (2011) 4.18

Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88

Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer (2004) 3.88

A geographically explicit genetic model of worldwide human-settlement history. Am J Hum Genet (2006) 3.81

Lineage-specific hematopoietic growth factors. N Engl J Med (2006) 3.73

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol (2003) 3.69

Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A (2002) 3.50

Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem (2002) 3.47

Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31

c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol (2002) 3.20

Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc Natl Acad Sci U S A (1996) 2.99

Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71

Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA (1999) 2.67

Helicobacter pylori in North and South America before Columbus. FEBS Lett (2002) 2.57

NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A (2005) 2.52

Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter (2010) 2.50

Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology (1997) 2.21

Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood (2008) 2.13

Helicobacter in the developing world. Microbes Infect (2003) 2.02

Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med (2005) 2.01

Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem (2004) 2.01

The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol (2010) 1.83

Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol (2001) 1.81

Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood (2003) 1.81

Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood (1989) 1.73

Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol (2005) 1.72

A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum (2003) 1.71

Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology (2003) 1.69

Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med (2004) 1.65

A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet (2010) 1.64

Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med (2005) 1.61

IgG receptor polymorphisms: risk factors for disease. Immunogenetics (1998) 1.59

Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter (1997) 1.54

Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study. Br J Haematol (2004) 1.53

The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med (2000) 1.53

[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. Korean J Gastroenterol (2009) 1.48

Functional association between the Helicobacter pylori virulence factors VacA and CagA. J Med Microbiol (2008) 1.44

Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults. Br J Haematol (2002) 1.42

Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol (2011) 1.37

Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol (2004) 1.30

Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer. J Clin Microbiol (2009) 1.25

High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood (1991) 1.25

Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. Microbes Infect (2003) 1.22

Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood (2002) 1.21

A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J Immunol (2004) 1.19

Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. J Antimicrob Chemother (2007) 1.19

Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem (2010) 1.18

Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood (2007) 1.18

Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol (2005) 1.17

Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol (2003) 1.16

Extragastric diseases and Helicobacter pylori. Helicobacter (2013) 1.14

Role of infected parents in transmission of helicobacter pylori to their children. Pediatr Infect Dis J (2002) 1.10

Current management of immune thrombocytopenia. Hematology Am Soc Hematol Educ Program (2013) 1.08

Recent progress in understanding the pathogenesis of immune thrombocytopenia. Curr Opin Hematol (2010) 1.07

Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem (2011) 1.06

Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol (2003) 1.04

Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites. Gut (1998) 1.02

Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol (2010) 1.02

Helicobacter pylori in the oral cavity and gastric mucosa: a meta-analysis. J Oral Pathol Med (2011) 1.01

Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med (2004) 1.01

Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts. Acta Haematol (2006) 1.00

Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol (2013) 1.00

Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest (2008) 0.99

Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol (2002) 0.98

Helicobacter pylori-associated immune thrombocytopenia. Platelets (2006) 0.97

Current options for the treatment of Helicobacter pylori. Expert Opin Pharmacother (2013) 0.97

Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol (2013) 0.97

Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J Gastroenterol (2014) 0.96

Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol (2002) 0.96

Comparative analysis of the full genome of Helicobacter pylori isolate Sahul64 identifies genes of high divergence. J Bacteriol (2013) 0.95

Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest (2005) 0.94

Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol (2010) 0.94

Treatment for H. pylori infection: new challenges with antimicrobial resistance. J Clin Gastroenterol (2013) 0.93

Correlation between IL-8 induction, cagA status and vacA genotypes in 153 French Helicobacter pylori isolates. Res Microbiol (2000) 0.92

Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter (2007) 0.90

Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter (2004) 0.89

Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. Haematologica (2006) 0.89

Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review. Int J Hematol (2003) 0.88

Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura. Int J Hematol (2008) 0.88

Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets (2005) 0.87

Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura. Hematology (2009) 0.87

B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun (2005) 0.87

Idiopathic thrombocytopenic purpura (ITP): clinical and immunologic considerations. Semin Thromb Hemost (1977) 0.87

Relationship between J-Western CagA subtype and the vacA m2 region of Helicobacter pylori. J Clin Microbiol (2010) 0.85

Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori is not associated with cagA, vacA or picB genotypes. APMIS (1999) 0.85

Platelet Count Response to Helicobacter pylori Eradication in Iranian Patients with Idiopathic Thrombocytopenic Purpura. Mediterr J Hematol Infect Dis (2012) 0.84

Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. Hematology Am Soc Hematol Educ Program (2012) 0.83